Investing

Description The securities of Lithium Universe Limited (‘LU7’) will be placed in trading halt at the request of LU7, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt…

Investor Insight With a strategic portfolio of oil and gas production and exploration projects, Trillion Energy is a compelling investment opportunity well-placed to play a critical role in Europe’s and Turkey’s energy market. Overview Trillion…

Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to Amplia’s Focal Adhesion Kinase inhibitor, narmafotinib, for…

The Saskatchewan Research Council’s (SRC) rare earths processing facility in Saskatoon is now producing rare earth metals at a commercial scale, the organization announced on Monday (September 16). The Canadian province is now the first…

The US Federal Reserve reduced its benchmark interest rate for the first time in four years on Wednesday (September 18), beginning its cutting cycle with a sizeable 50 basis point reduction. The Federal Open Market…

Investor Insight An innovative technology that promises positive economics place Altech Batteries in a compelling position to take advantage of a booming batteries market driven by global electrification and clean energy transition. Overview Altech Batteries…

Falcon Gold Corp.(TSXV:FG)(3FA:GR)(OTCQB:FGLDF); (‘Falcon’ or the ‘Company’) is pleased to report drilling has commenced at our Great Burnt Copper Project (the ‘Property’) located in Central Newfoundland. The Company has completed 8kms of additional road to…

NioCorp Developments (NASDAQ:NB) said on Wednesday (September 18) that it will discuss its plans for producing and potentially recycling rare earth elements at the International Rare Earths Conference. The event will be held in Washington,…

The pharmaceutical industry is a major player in the overall life science sector, responsible for developing and manufacturing the majority of prescription drugs. Companies in this space are constantly researching and creating innovative treatments for…

Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to report that on 18 September 2024, it had completed the issue of shares in part settlement of deferred executive salaries and director…